Targeting Lactate Dehydrogenase-B as a Strategy to Fight Cancer: Identification of Potential Inhibitors by In Silico Analysis and In Vitro Screening
Lactate dehydrogenase (LDH) is an enzyme that catalyzes the reversible conversion of lactate to pyruvate while reducing NAD<sup>+</sup> to NADH (or oxidizing NADH to NAD<sup>+</sup>). Due to its central role in the Warburg effect, LDH-A isoform has been considered a promising...
Saved in:
Main Authors: | Manos Vlasiou (Author), Vicky Nicolaidou (Author), Christos Papaneophytou (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Targeting mitochondrial dysfunction for the diagnosis and treatment of Alzheimer's and cognitive-related diseases
by: Manos C. Vlasiou, et al.
Published: (2024) -
Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases
by: Jung Ho Han, et al.
Published: (2023) -
Short-Chained Linear Scorpion Peptides: A Pool for Novel Antimicrobials
by: Tolis Panayi, et al.
Published: (2024) -
Lactate Dehydrogenase is involved in but not the Target Antigen in Children with Kawasaki Disease
by: Lanqing Zhao, et al.
Published: (2016) -
Lactate Dehydrogenase A or B Knockdown Reduces Lactate Production and Inhibits Breast Cancer Cell Motility in vitro
by: Maitham A. Khajah, et al.
Published: (2021)